Epigenetic Landscape of Head and Neck Carcinomas
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: closed (15 June 2024) | Viewed by 215
Special Issue Editor
Interests: carcinogenesis; cancer progression; metastasis signaling; preclinical and animal models; genetic, genomic and epigenomic; target and drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Epigenetic modifications, including DNA methylation, histone modifications, chromatin remodeling, and non-coding RNA regulation, have emerged as pivotal players in the pathogenesis and tumor progression of head and neck carcinomas. Understanding the nuances of the epigenetic landscape in head and neck carcinomas not only unravels the underlying molecular mechanisms but also holds immense potential for the development of epigenetic-targeted therapies and precision medicine approaches to combat these aggressive malignancies.
In this Special Issue, we invite researchers and clinicians to submit original research articles, reviews, mini-reviews, and perspectives that delve into the complex epigenetic underpinnings of head and neck carcinomas. Through this Special Issue, we aim to foster collaboration and the exchange of ideas to advance our understanding of epigenetic mechanisms in these malignancies and to facilitate the translation of these insights into innovative therapeutic strategies.
Dr. Sabrina Daniela da Silva
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- epigenetics
- head and neck carcinomas
- DNA methylation
- histone modifications
- chromatin remodeling
- non-coding RNAs
- tumor microenvironment
- epitranscriptomics
- cancer epigenomics
- precision oncology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
